TERMINATION AGREEMENTTermination Agreement • September 18th, 2017 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 18th, 2017 Company Industry JurisdictionTHIS TERMINATION AGREEMENT (this “Termination Agreement”) is made and entered into effective as of the Termination Effective Date by and between IMMUNOMEDICS, INC., a Delaware corporation (“IMMU”), and SEATTLE GENETICS, INC., a Delaware corporation (“SGEN”). Each of IMMU and SGEN may be referenced herein individually as a “Party” and collectively as the “Parties”.